Activation of RNase L by murine coronavirus in myeloid cells is dependent on basal Oas gene expression and independent of virus-induced interferon

Journal of Virology

Volumn 90, Issue 6, 2016, Pages 3160-3172

  Birdwell, L Dillon ^a   Zalinger, Zachary B ^a   Li, Yize ^a   Wright, Patrick W ^b   Elliott, Ruth ^a   Rose, Kristine M ^a,d   Silverman, Robert H ^c   Weiss, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MESSENGER RNA; RIBONUCLEASE L; 2',5' OLIGOADENYLATE SYNTHETASE; 2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE; GENE EXPRESSION; MOUSE; MURINE CORONAVIRUS; NONHUMAN; OLIGOADENYLATE SYNTHETASE GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; HOST PATHOGEN INTERACTION; KNOCKOUT MOUSE; METABOLISM; MURINE HEPATITIS VIRUS; PHYSIOLOGY; VIROLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; CELLS, CULTURED; ENDORIBONUCLEASES; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; MICE; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; MYELOID CELLS;

EID: 84961158252     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03036-15     Document Type: Article

References (67)

1. Navas-Martin S, Weiss SR. 2003. SARS: lessons learned from other coronaviruses. Viral Immunol 16:461-474. http://dx.doi.org/10.1089/088282 403771926292.
2. Zhao L, Rose KM, Elliott R, Van Rooijen N, Weiss SR. 2011. Cell-typespecific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol 85:10058-10068. http://dx.doi.org/10.1128/JVI.05075-11.
3. Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR. 1984. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34:597-603. http://dx.doi.org/10.1212/WNL.34.5.597.
4. Marten NW, Stohlman SA, Atkinson RD, Hinton DR, Fleming JO, Bergmann CC. 2000. Contributions of CD8+ T cells and viral spread to demyelinating disease. J Immunol 164:4080-4088. http://dx.doi.org/10.4049/jimmunol.164.8.4080.
5. Marten NW, Stohlman SA, Bergmann CC. 2001. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol 14:1-18. http://dx.doi.org/10.1089/08828240151061329.
6. Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. 2008. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 82:300-310. http://dx.doi.org/10.1128/JVI.01794-07.
7. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82:9829-9838. http://dx.doi.org/10.1128/JVI.01199-08.
8. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
9. Kumagai Y, Takeuchi O, Akira S. 2008. Pathogen recognition by innate receptors. J Infect Chemother 14:86-92. http://dx.doi.org/10.1007/s10156-008-0596-1.
10. Takeuchi O, Akira S. 2007. Recognition of viruses by innate immunity. Immunol Rev 220:214-224. http://dx.doi.org/10.1111/j.1600-065X.2007.00562.x.
11. Dong B, Silverman RH. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270:4133-4137. http://dx.doi.org/10.1074/jbc.270.8.4133.
12. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819. http://dx.doi.org/10.1038/nature06042.
13. Silverman RH. 2007. Viral encounters with 2=,5=-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 81: 12720-12729. http://dx.doi.org/10.1128/JVI.01471-07.
14. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH. 1997. Interferon action and apoptosis are defective in mice devoid of 2=,5=-oligoadenylatedependent RNase L EMBO J 16:6355-6363.
15. Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM, Vukmanovic S, Garcia-Sastre A, Levy DE. 2000. Type I IFN modulates innate and specific antiviral immunity. J Immunol 164:4220-4228. http://dx.doi.org/10.4049/jimmunol.164.8.4220.
16. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921. http://dx.doi.org/10.1126/science.8009221.
17. Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W, Ludewig B, Reizis B. 2012. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A 109:3012-3017. http://dx.doi.org/10.1073/pnas.1117359109.
18. Silverman RH. 2007. A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev 18:381-388. http://dx.doi.org/10.1016/j.cytogfr.2007.06.012.
19. Kakuta S, Shibata S, Iwakura Y. 2002. Genomic structure of the mouse 2=,5=-oligoadenylate synthetase gene family. J Interferon Cytokine Res 22: 981-993. http://dx.doi.org/10.1089/10799900260286696.
20. Mashimo T, Glaser P, Lucas M, Simon-Chazottes D, Ceccaldi PE, Montagutelli X, Despres P, Guenet JL. 2003. Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2=,5=-oligoadenylate synthetases. Genomics 82:537-552. http://dx.doi.org/10.1016/S0888-7543(03)00176-9.
21. Silverman RH, Weiss SR. 2014. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A. J Interferon Cytokine Res 34:455-463. http://dx.doi.org/10.1089/jir.2014.0007.
22. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264. http://dx.doi.org/10.1146/annurev.biochem.67.1.227.
23. Castelli J, Wood KA, Youle RJ. 1998. The 2-5A system in viral infection and apoptosis. Biomed Pharmacother 52:386-390. http://dx.doi.org/10.1016/S0753-3322(99)80006-7.
24. Castelli JC, Hassel BA, Maran A, Paranjape J, Hewitt JA, Li XL, Hsu YT, Silverman RH, Youle RJ. 1998. The role of 2=-5= oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ 5:313-320. http://dx.doi.org/10.1038/sj.cdd.4400352.
25. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. 2012. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11:607-616. http://dx.doi.org/10.1016/j.chom.2012.04.011.
26. Sorgeloos F, Jha BK, Silverman RH, Michiels T. 2013. Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L. PLoS Pathog 9:e1003474. http://dx.doi.org/10.1371/journal.ppat.1003474.
27. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
28. Han JQ, Townsend HL, Jha BK, Paranjape JM, Silverman RH, Barton DJ. 2007. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 81:5561-5572. http://dx.doi.org/10.1128/JVI.01857-06.
29. Zhao L, Birdwell LD, Wu A, Elliott R, Rose KM, Phillips JM, Li Y, Grinspan J, Silverman RH, Weiss SR. 2013. Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus. J Virol 87:8408-8418. http://dx.doi.org/10.1128/JVI.00769-13.
30. Taniguchi T, Takaoka A. 2001. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2:378-386. http://dx.doi.org/10.1038/35073080.
31. Sato M, Taniguchi T, Tanaka N. 2001. The interferon system and interferon regulatory factor transcription factors: studies from gene knockout mice. Cytokine Growth Factor Rev 12:133-142. http://dx.doi.org/10.1016/S1359-6101(00)00032-0.
32. Gombold JL, Hingley ST, Weiss SR. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol 67:4504-4512.
33. Zhou A, Paranjape JM, Hassel BA, Nie H, Shah S, Galinski B, Silverman RH. 1998. Impact of RNase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 18:953-961.
34. Roth-Cross JK, Stokes H, Chang G, Chua MM, Thiel V, Weiss SR, Gorbalenya AE, Siddell SG. 2009. Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J Virol 83:3743-3753. http://dx.doi.org/10.1128/JVI.02203-08.
35. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDVVprotein and the Nipah virus V, W, andCproteins. J Virol 77:1501-1511. http://dx.doi.org/10.1128/JVI.77.2.1501-1511.2003.
36. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103:8459-8464. http://dx.doi.org/10.1073/pnas.0603082103.
37. Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS. 2011. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog 7:e1002407. http://dx.doi.org/10.1371/journal.ppat.1002407.
38. Casson CN, Copenhaver AM, Zwack EE, Nguyen HT, Strowig T, Javdan B, Bradley WP, Fung TC, Flavell RA, Brodsky IE, Shin S. 2013. Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. PLoS Pathog 9:e1003400. http://dx.doi.org/10.1371/journal.ppat.1003400.
39. Caamano J, Alexander J, Craig L, Bravo R, Hunter CA. 1999. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol 163:4453-4461.
40. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702. http://dx.doi.org/10.1084/jem.176.6.1693.
41. Copenhaver AM, Casson CN, Nguyen HT, Fung TC, Duda MM, Roy CR, Shin S. 2014. Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion. Infect Immun 82:4325-4336. http://dx.doi.org/10.1128/IAI.01891-14.
42. Bender SJ, Phillips JM, Scott EP, Weiss SR. 2010. Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread. J Virol 84:11030-11044. http://dx.doi.org/10.1128/JVI.02688-09.
43. Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD. 2006. Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J Interferon Cytokine Res 26:804-819. http://dx.doi.org/10.1089/jir.2006.26.804.
44. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH. 2003. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2=,5=-oligoadenylates. Cancer Res 63:6795-6801.
45. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. 2006. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3. http://dx.doi.org/10.1186/1471-2199-7-3.
46. Zhou Y, Kang MJ, Jha BK, Silverman RH, Lee CG, Elias JA. 2013. Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol 191:2637-2646. http://dx.doi.org/10.4049/jimmunol.1300082.
47. Knijnenburg TA, Roda O, Wan Y, Nolan GP, Aitchison JD, Shmulevich I. 2011. A regression model approach to enable cell morphology correction in high-throughput flow cytometry. Mol Syst Biol 7:531. http://dx.doi.org/10.1038/msb.2011.64.
48. Cooper DA, Banerjee S, Chakrabarti A, Garcia-Sastre A, Hesselberth JR, Silverman RH, Barton DJ. 2015. RNase L targets distinct sites in influenza A virus RNAs. J Virol 89:2764-2776. http://dx.doi.org/10.1128/JVI.02953-14.
49. Roth-Cross JK, Martinez-Sobrido L, Scott EP, Garcia-Sastre A, Weiss SR. 2007. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol 81:7189-7199. http://dx.doi.org/10.1128/JVI.00013-07.
50. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36:166-174. http://dx.doi.org/10.1016/j.immuni.2012.01.011.
51. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http://dx.doi.org/10.1016/S1074-7613(00)00053-4.
52. Lazear HM, Pinto AK, Vogt MR, Gale M, Jr, Diamond MS. 2011. Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol 85:7186-7194. http://dx.doi.org/10.1128/JVI.00396-11.
53. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, Sheehan K, Hilton DJ, Alexander WS, Hertzog PJ. 2006. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 7:33-39. http://dx.doi.org/10.1038/ni1287.
54. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BR, Silverman RH, Gale M, Jr, Diamond MS. 2006. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80:7009-7019. http://dx.doi.org/10.1128/JVI.00489-06.
55. Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon LL, Baric RS, Nicholls JM, Peiris JS. 2013. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87:6604-6614. http://dx.doi.org/10.1128/JVI.00009-13.
56. Spiegel M, Pichlmair A, Martinez-Sobrido L, Cros J, Garcia-Sastre A, Haller O, Weber F. 2005. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79:2079-2086. http://dx.doi.org/10.1128/JVI.79.4.2079-2086.2005.
57. Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. 2007. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361:18-26. http://dx.doi.org/10.1016/j.virol.2007.01.020.
58. Kindler E, Jonsdottir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RA, Drosten C, Muller MA, Dijkman R, Thiel V. 2013. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4:e00611-00612. http://dx.doi.org/10.1128/mBio.00611-12.
59. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY, Lau SK, Woo PC, Yuen KY. 2013. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 207:1743-1752. http://dx.doi.org/10.1093/infdis/jit123.
60. Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, Becker S, Weber F. 2013. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 87:5300-5304. http://dx.doi.org/10.1128/JVI.03496-12.
61. Trinchieri G. 2010. Type I interferon: friend or foe? J Exp Med 207:2053-2063. http://dx.doi.org/10.1084/jem.20101664.
62. de Visser KE, Eichten A, Coussens LM. 2006. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37. http://dx.doi.org/10.1038/nrc1782.
63. Hata N, Sato M, Takaoka A, Asagiri M, Tanaka N, Taniguchi T. 2001. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem Biophys Res Commun 285:518-525. http://dx.doi.org/10.1006/bbrc.2001.5159.
64. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739. http://dx.doi.org/10.1016/0092-8674(89)90107-4.
65. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623-655. http://dx.doi.org/10.1146/annurev.immunol.19.1.623.
66. Lubick KJ, Robertson SJ, McNally KL, Freedman BA, Rasmussen AL, Taylor RT, Walts AD, Tsuruda S, Sakai M, Ishizuka M, Boer EF, Foster EC, Chiramel AI, Addison CB, Green R, Kastner DL, Katze MG, Holland SM, Forlino A, Freeman AF, Boehm M, Yoshii K, Best SM. 2015. Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe 18:61-74. http://dx.doi.org/10.1016/j.chom.2015.06.007.
67. Zurney J, Howard KE, Sherry B. 2007. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J Virol 81:13668-13680. http://dx.doi.org/10.1128/JVI.01172-07.